Dicipan

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dicipan

What is Dicipan? (Overview and Quick Facts)

Dicipan is a systemic medication whose active ingredient is Diclofenac Sodium, which fundamentally places it in the Non-Steroidal Anti-Inflammatory Drug (NSAID) class. This medicine is a synthetic, single-ingredient product designed for oral administration, providing an established option for managing discomfort associated with inflammation.

Property Description
Active ingredient Diclofenac Sodium
Form Tablets/Capsules (Oral)
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Common use Relief of pain, inflammation, and fever
Origin Synthetic (Benzeneacetic acid derivative)

Defining Dicipan: Identity and Pharmacological Classification

Dicipan contains the internationally recognized chemical entity Diclofenac Sodium, which is the active pharmaceutical ingredient (API). The compound itself is a synthetic derivative categorized as a benzeneacetic acid derivative. Diclofenac is formally classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID), a major pharmaceutical class recognized for modifying the body's physical response to injury or illness. Diclofenac acts primarily through the inhibition of cyclooxygenase (COX) enzymes. This mechanism means the medicine works by blocking the body's chemical pathways that generate pain and inflammatory signals.


Composition and Physical Form

The core of Dicipan is the active substance Diclofenac, a member of the phenylacetic acid family. As an oral systemic drug, Dicipan is typically presented in solid dosage forms, such as tablets or capsules, which are taken by mouth. Specialized forms, including enteric-coated or delayed-release preparations, are often employed in Dicipan's formulation to control the medicine's rate of absorption and manage its journey through the digestive system. This design, intended for oral administration, helps maximize its effectiveness for systemic symptomatic relief.


General Therapeutic Purpose

The overarching purpose of taking Dicipan is to provide comprehensive symptomatic relief by combining its key pharmacological effects. Consistent with its NSAID classification, Dicipan primarily functions to reduce pain (analgesic action), lessen physical inflammation (anti-inflammatory action), and assist in lowering fever (antipyretic action). Diclofenac is a potent anti-inflammatory agent used across various conditions. This means the general benefit of Dicipan is to manage the symptoms of discomfort and acute physical responses throughout the body. Its use is established for providing relief in scenarios where pain and inflammation are co-occurring factors.

Regulatory References

  1. Diclofenac Sodium Label (DailyMed/FDA)
  2. NIH Diclofenac StatPearls Review
  3. NIH StatPearls Review on Diclofenac

What side effects are possible with Dicipan?

Possible side effects and safety information

Official government regulatory documents classify and organize the safety profile of Dicipan based on the frequency and severity of reported adverse reactions.

Adverse Reaction Categories

Adverse effects are documented according to the affected System Organ Class (SOC), with key areas including:

  • Gastrointestinal Disorders: Effects ranging from mild discomfort to serious events like inflammation, bleeding, ulceration, and perforation.
  • Nervous System Disorders: Reactions such as headache or dizziness.
  • Cardiac and Vascular Disorders: Potential for increased risk of thrombotic events, including myocardial infarction (heart attack) and stroke, as well as hypertension and fluid retention (edema).
  • Hepatobiliary Disorders: Risk of liver toxicity (hepatotoxicity).
  • Renal and Urinary Disorders: Potential for kidney-related adverse effects.

Regulatory documentation assigns a frequency classification (e.g., Very Common, Common, Rare) to specific adverse reactions based on their rate of occurrence in clinical trials.

Serious Adverse Reactions and Restrictions

Serious Adverse Reactions that can be life-threatening and require immediate medical attention are highlighted in official documents. These typically include Serious Cardiovascular Thrombotic Events, severe Gastrointestinal Bleeding, Ulceration, and Perforation, and serious skin reactions (e.g., DRESS).

Safety-related restrictions define limitations on the drug’s use. Dicipan is contraindicated (should not be used) in patients with a known history of asthma, urticaria, or allergic-type reactions to aspirin or other NSAIDs. Use is also restricted in the setting of coronary artery bypass graft (CABG) surgery and in patients with advanced heart failure or severe renal impairment. Risk of certain serious events is documented to increase with higher doses and longer duration of use.

Overdose and Emergency Response

Overdose and When to Seek Help — Official Regulatory Information for Dicipan

Regulatory documentation defines the Dicipan (Diclofenac Sodium) overdose profile based on documented symptom clusters and mandated emergency actions. A suspected or confirmed large overdose requires immediate medical attention.

Category Official Regulatory Statements
Documented Manifestations Symptoms may include nausea, vomiting, epigastric pain, headache, drowsiness, tinnitus, and confusion [Source: Regulatory Documentation].
Severe Outcomes Life-threatening manifestations can involve acute renal failure, seizures, coma, and significant gastrointestinal bleeding [Source: Regulatory Documentation].
Emergency Actions Seek immediate medical attention or contact emergency services/Poison Control right away [Source: Regulatory Documentation]. No specific antidote is known for Diclofenac overdose.
Supportive Measures Treatment is symptomatic and supportive. Procedures such as gastric lavage and activated charcoal are described if ingestion was recent, alongside monitoring of vital signs and laboratory tests [Source: Regulatory Documentation].
Population Notes A large overdose is officially documented as being very harmful to children and adults. Patients with asthma may experience exacerbated respiratory symptoms like wheezing [Source: Regulatory Documentation].

Official Regulatory Statement Summary: The regulatory profile for Dicipan mandates that any suspected overdose, especially one involving severe signs like convulsions or renal failure, must trigger an immediate call for emergency medical help. Management relies on symptomatic and supportive care, as documented in prescribing information, and includes hospital monitoring of vital signs and laboratory parameters.

Therapeutic Uses of Dicipan

What Dicipan Treats: Main Uses and Benefits

Dicipan is a medication commonly used for short-term, supportive relief across certain clinical scenarios characterized by heightened patient distress. As a formulation of Diazepam, it is considered relevant for easing symptoms related to heightened physiological activity, systemic imbalance, and conditions involving episodic or fluctuating manifestations. Its primary role may help offer supportive relief in clinical settings that involve acute or unstable symptom patterns.


Managing Acute Symptom Clusters

This medicine is applied across domains where additional symptomatic support is needed to help address symptom clusters that may become intense or disruptive. It is relevant in contexts marked by increased discomfort or tension, such as conditions involving heightened physiological stress. In these situations, Dicipan is commonly used to help patients cope more steadily during difficult episodes and contributes to easing the overall symptom load.

Quick Fact: Relief for Intense Episodic Symptoms


Support for Fluctuating Symptom Patterns

Dicipan is applicable within clinical settings that involve acute or disruptive symptom patterns, particularly in conditions characterized by periods of heightened symptoms. When symptoms intensify, this treatment may be part of symptomatic management to help with symptom fluctuations, and assists with maintaining functional stability during phases where temporary strain is present.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Eligibility Profile for Dicipan (Diclofenac Sodium)

Official regulatory documents strictly define the patient populations eligible to use Dicipan, based on the drug's classification as an NSAID (Diclofenac Sodium).


Absolute Contraindications (Must Not Use)

  • Hypersensitivity: Patients with known allergy to Diclofenac or a history of allergic reactions, such as Aspirin-sensitive asthma, after taking any NSAID.
  • Cardiovascular Surgery: Patients receiving treatment for pain following Coronary Artery Bypass Graft (CABG) surgery.
  • Severe Organ Failure: Individuals with Severe Heart Failure (NYHA Class II–IV), Severe Hepatic Failure, or Severe Renal Failure.
  • Gastrointestinal Risk: Patients with active gastrointestinal ulceration, bleeding, or perforation.
  • Pregnancy: Use is contraindicated starting at 30 weeks gestation (third trimester) and later.

Age and Population Restrictions

Population Group Eligibility Status Restriction Notes
Pediatric Patients Not Established Safety and effectiveness are typically not established for most oral forms in children under 12 years of age.
Older Adults Use with Caution At greater risk for serious adverse reactions, particularly gastrointestinal bleeding.
Lactation Use with Caution Diclofenac is excreted into human milk.

Regulatory agencies limit use to the lowest effective dose for the shortest duration possible for patients with risk factors, including those with a history of heart disease, past GI issues, or use between 20 and 30 weeks gestation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Dicipan (Diclofenac Sodium) has officially documented interaction patterns based on regulatory classification, primarily falling under pharmacodynamic risk intensification and pharmacokinetic modulation.

Contraindicated Combinations

Regulatory documents formally state that co-administration is prohibited for certain combinations due to serious risk:

  • Other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Salicylates (e.g., high-dose Aspirin): These are contraindicated due to an additive risk of serious gastrointestinal (GI) toxicity and bleeding.
  • Per-operative pain management in the setting of Coronary Artery Bypass Graft (CABG) surgery is a contraindicated use.

Pharmacodynamic and Exposure-Altering Interactions

These interactions increase the risk of adverse events or alter drug concentrations in the plasma:

  • Increased Bleeding Risk: Co-administration with Anticoagulants (e.g., Warfarin), Antiplatelet agents, Corticosteroids, and SSRIs is documented to increase the overall risk of GI bleeding.
  • Renal Risk and Reduced Efficacy: Combined use with Diuretics or ACE/ARBs is documented to increase the risk of acute renal failure and may reduce the antihypertensive or diuretic effect.
  • Increased Plasma Levels: Dicipan is documented to increase the plasma concentrations (exposure) of co-administered medicines such as Lithium, Digoxin, and Methotrexate.
  • Metabolic Interaction: Substances classified as CYP2C9 Inhibitors are documented to increase Dicipan's plasma exposure, while CYP2C9 Inducers may decrease it.

Other Documented Interactions

  • Food: For non-enteric coated forms, food intake is documented to decrease the rate and extent of the medicine's absorption.
  • Population Note: The elderly population is documented to have an increased susceptibility to serious adverse events from these interactions, particularly those involving the GI, renal, and cardiac systems.

Mechanism of Action

The Core Mechanism: COX Enzyme Inhibition and Prostaglandin Reduction

This primary mechanism operates through the non-selective inhibition of Cyclooxygenase (COX-1 and COX-2) enzymes . By blocking these enzymes, Dicipan suppresses the conversion of arachidonic acid into prostaglandins—the key molecular messengers that sensitize nociceptors, drive the inflammatory response, and elevate the body's thermoregulatory set point. This action modulates the upstream chemical signaling associated with heightened physiological responses, leading to the systemic reduction of nociceptive signaling and the resetting of the thermoregulatory set point.

Secondary Mechanism: Direct Neuronal Channel Blockade

Dicipan's action extends beyond enzyme inhibition to include direct modulation of nerve signaling, primarily through the blockade of voltage-dependent sodium channels and acid-sensing ion channels (ASICs) in peripheral sensory neurons. This mechanism is distinct from prostaglandin reduction, as it targets the electrical transmission of signals rather than the chemical initiation. By stabilizing the nerve cell membrane, this action directly dampens the excitability of nerve endings, assisting in limiting the transmission of nociceptive signals within the nervous system.

Mechanistic Constraint: Impact on Constitutive COX-1 Function

The mechanism's non-selective nature means it also affects the constitutive COX-1 enzyme, which is responsible for producing prostaglandins vital for maintaining normal physiological functions, such as blood vessel regulation and protection of the stomach lining. This functional constraint means the mechanism inherently influences these protective biological processes.

Dosage and Administration Information

How to Use Dicipan: Administration Guidelines

Dicipan (Diclofenac Sodium) is administered either orally (as tablets, capsules, or powder for solution) or intravenously (IV), with the IV route generally reserved for supervised clinical settings. General guidelines recommend using the lowest effective dose for the shortest duration consistent with the overall treatment goal.

Dosing and Administration

Usage Parameter General Administration (Oral Forms)
Dosing Range Varies by condition; typically 100 mg to 200 mg per day in divided doses. The maximum daily dose for delayed-release tablets is 150 mg or 200 mg, depending on the formulation.
Frequency Once daily (for extended-release forms), or in divided doses (two to four times daily) for immediate or delayed-release tablets.
Timing & Food Delayed-release tablets may be taken with or without food, though taking them with food can delay absorption. The powder for oral solution is recommended to be taken on an empty stomach after mixing with 1 to 2 ounces of water.
Handling Delayed-release and extended-release tablets must be swallowed whole and must not be crushed, chewed, or broken.

Procedural and Population Rules

Dosage forms are generally not interchangeable on a milligram-for-milligram basis due to varying absorption properties. For older adults, guidelines suggest starting at the lowest effective dose. If a dose is missed, it should be taken as soon as remembered, but if it is almost time for the next scheduled dose, the user must skip the missed dose. Doubling the dose is prohibited.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Dicipan (Diclofenac Sodium, Oral)


Evidence for Short-Term Relief of Acute Pain and Inflammation

Research examining Dicipan was evaluated for use in acute pain episodes relies heavily on short-term, controlled clinical trials, known as Randomized Controlled Trials (RCTs). These studies often compare the medication to a non-active substitute (placebo). Researchers use these trials to measure outcomes related to physical discomfort and to observe how symptoms change over defined, short time intervals, typically a few hours up to a few days. Studies conducted during these periods of increased symptom activity reported patterns observed in the groups receiving Dicipan compared to those receiving placebo.

Reports indicated that the measured outcomes showed patterns of difference when compared to the measurements reported for the placebo groups. This research provides insight into short-term changes. However, the evidence primarily covers a limited period of use, and there is limited information for long-term outcomes or repeated use for recurrent acute episodes.


Scientific Research Gaps and Areas of Uncertainty

The body of research for Dicipan contributes to understanding symptom patterns, but scientific reviews have identified several research gaps and areas where clarity remains low. One primary limitation is that comparative evidence is lacking for many common, over-the-counter analgesic options. Another major area where data are still emerging is in the comprehensive understanding of systemic effects associated with very long-term continuous use (multiple years) in high-risk groups.

Studies have monitored the use in older adult populations. However, data for certain groups, such as children or pregnant populations, remain insufficient or limited. The core evidence regarding outcomes related to short-term changes is available from multiple studies, but the available research provides context but not individual predictions regarding long-term response or tolerability.

Frequently Asked Questions (FAQ)

Common questions about Dicipan (FAQ)


Q: Is Dicipan considered a long-term treatment option?

Official guidelines emphasize that Dicipan, like all NSAIDs, should be used at the lowest effective dose for the shortest duration necessary to meet the treatment goal. This instruction is based on evidence that risks associated with the medicine may increase with both the dose and the length of treatment.


Q: Does Dicipan cause changes in energy levels?

Official product information states that reported side effects can include central nervous system effects such as dizziness and drowsiness. These documented effects may indirectly influence how a person perceives their energy levels.


Q: Are there any common side effects that usually go away after a few days of taking Dicipan?

Some documented side effects, such as initial dizziness or headaches, are described in patient information as effects that may lessen as the body adjusts to the medicine. However, if any symptom becomes bothersome or persists, it is appropriate to seek advice from a health professional.


Q: Can Dicipan affect sleep patterns?

Yes, the official product information lists central nervous system effects that can impact sleep. Documented side effects include insomnia (difficulty sleeping) or, conversely, drowsiness.


Q: Is it normal to feel [vague sensation like tired/dizzy] when starting Dicipan?

Dizziness is listed as a common potential side effect of Dicipan, and drowsiness or fatigue is also a documented possible side effect that may be experienced at the start of treatment.


Q: Are there any specific foods to avoid while taking Dicipan?

Official warnings state that the oral powder formulation should be taken on an empty stomach for proper absorption. For other oral forms, taking the medicine with food may slow down the rate at which the active ingredient enters the body.


Q: What are the most commonly reported side effects in research studies on Dicipan?

Studies and official documents indicate that the most commonly reported side effects generally involve the gastrointestinal system. These typically include stomach pain, indigestion (dyspepsia), nausea, constipation, diarrhea, headache, and dizziness.


Q: What is the difference between a common side effect and a serious side effect of Dicipan?

A common side effect is one frequently observed in clinical studies, such as headache or stomach upset. A serious side effect is rare but poses a potential risk to health (e.g., severe GI bleeding or a cardiovascular event) and requires immediate medical attention.


Q: Are the effects of Dicipan immediate or do they build up over time?

Official pharmacological data indicates that the active ingredient is absorbed rapidly, with maximum concentration in the blood typically reached within a few hours. For long-term inflammatory conditions, the full anti-inflammatory benefit may take longer to build up.


Q: What kind of monitoring is typically done when taking Dicipan?

For patients who are taking the medicine long-term, regulatory documentation indicates that regular monitoring of certain functions is indicated as a precautionary measure. This monitoring typically involves checks on blood pressure and on kidney (renal) and liver (hepatic) function.


Q: How do I know if Dicipan is working for me?

The general purpose of Dicipan is to manage the symptoms of pain, inflammation, and stiffness. Therefore, the medicine is considered to be working when the symptoms related to the condition for which it was prescribed begin to improve or lessen.


Q: Is Dicipan safe for people with liver issues, based on official information?

Dicipan is contraindicated (must not be used) in patients with severe hepatic (liver) failure. Official information states that caution and close medical monitoring are required for people who have mild to moderate hepatic impairment.


Q: What is the recommended age range for Dicipan use, according to the label?

The safety and effectiveness of most oral forms of Dicipan are not established for children under 12 years of age. For older adults, official guidance recommends using the lowest effective dose due to an increased susceptibility to certain risks.


Q: How long does Dicipan stay in your system after stopping treatment?

Official pharmacokinetic data shows that the medicine is eliminated from the body relatively quickly. The time it takes for half of the active ingredient to be removed from the plasma (the half-life) is generally short, typically ranging from one to three hours.


Q: Why do doctors prescribe Dicipan for different conditions?

Dicipan is officially approved to treat various conditions involving pain and inflammation due to its primary action as an anti-inflammatory drug. This includes chronic conditions like osteoarthritis and rheumatoid arthritis, as well as acute pain management.


Q: Is there a risk of dependency or withdrawal symptoms when stopping Dicipan?

As an NSAID, Dicipan is not associated with the risk of dependency or psychological addiction. Official sources indicate that it does not cause the typical withdrawal symptoms seen when stopping controlled substances or opioid medications.


Q: Can Dicipan be taken with common vitamins or minerals?

Official drug interaction lists typically focus on prescription medicines rather than general supplements. There is limited information, but some specific interactions with certain vitamins or supplements are elements that should be noted.


Q: Does Dicipan interact with alcohol?

Official warnings state that combining Dicipan with large amounts of alcohol may increase the risk of serious side effects. Specifically, the risk of stomach or intestinal bleeding, ulcers, or perforation may be elevated.


Q: Are there any long-term side effects noted in the Dicipan research?

Official guidance indicates that long-term, high-dose use of Dicipan carries increased risk for serious health issues. These noted risks include a higher likelihood of cardiovascular events, kidney failure, and gastrointestinal ulceration or bleeding.


Q: What is the general duration of treatment with Dicipan?

For managing short-term, acute pain from injuries or flares, treatment may only be needed for a few days. For long-term inflammatory conditions, the doctor will determine the shortest necessary duration required to manage symptoms.


Q: Why do official documents mention specific patient populations for Dicipan?

Official documents highlight specific groups, such as older adults or those with pre-existing heart or kidney conditions, to draw attention to increased risk. These groups are documented to have a greater chance of experiencing serious adverse events when taking the medicine.


Q: Does Dicipan need to be taken at a specific time of day?

Official information states that for forms taken two or more times a day, the timing should be spread evenly throughout the day. Slow-release forms may be taken once daily or split between morning and evening, depending on the prescribed schedule.


Q: Is there any evidence suggesting Dicipan can affect fertility?

Official information indicates that anti-inflammatory medicines like Dicipan may affect ovulation in women when used for a long time or in high doses. This potential temporary effect may make it more difficult to become pregnant.


Q: Does Dicipan have any interactions with birth control pills?

The medicine itself is not noted to directly reduce the effectiveness of oral contraceptives. However, if severe side effects like vomiting or diarrhea occur while using the combined oral contraceptive pill, there is a possibility that its effectiveness may be compromised.


Q: Is Dicipan a controlled substance?

No, Dicipan (Diclofenac) is officially classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). It is not designated or regulated as a controlled substance.


Q: Can Dicipan cause sun sensitivity?

Photosensitivity reactions, which means an increased sensitivity to sunlight, are documented as a rare potential side effect of Dicipan. It is noted in the adverse reaction information.


Q: What should I do if a minor side effect of Dicipan seems to persist?

Official patient information advises that if minor symptoms persist, do not improve within the expected duration, or become severe, it is appropriate to seek medical advice. This includes persistent headaches or dizziness.


Q: Are there any warnings about Dicipan and driving or operating machinery?

Yes, official warnings advise caution regarding activities that require alertness. Side effects such as dizziness or drowsiness may temporarily impair a person’s ability to safely operate machinery or drive.

How should Dicipan be stored and disposed of?

Storage and Disposal Requirements

Dicipan (Diclofenac Sodium) must be stored under specific environmental conditions to maintain its stability.


️ Storage Conditions

Requirement Details
Temperature Store at controlled room temperature, 20 C to 25 C (68 F to 77 F).
Protection Keep away from freezing, moisture, and direct light.
Packaging Store in the original container and keep it tightly closed.
Safety Must be kept out of the sight and reach of children.

️ Disposal Instructions

Unused or expired Dicipan must not be thrown away in household trash or poured down a sink or toilet. Disposal should follow pharmaceutical waste guidelines. Consult a pharmacist or healthcare professional for instructions on local drug take-back programs or proper disposal methods, which help protect the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dicipan found in:

A-Z Index: